Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2009-01-23

Original market date: See footnote 1

2003-02-11

Product name:

REFACTO

DIN:

02245951 Electronic product monograph is not available

Company:

WYETH CANADA
1025 Boulevard Marcel Laurin
St. Laurent
Quebec
Canada H4R 1J6

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

20:28.16 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B02BD02 COAGULATION FACTOR VIII

Active ingredient group (AIG) number:See footnote5

0147521001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
MOROCTOCOG ALFA 1000 UNIT / VIAL
Version 4.0.3

"Page details"

Date modified: